Efficacy of paliperidone palmitate 3-month formulation in preventing hospital admissions and emergency room visits. 66 months of follow-up

INTRODUCTION: Paliperidone Palmitate 3-month formulation (PP3M) has shown a significantly longer time to relapse compared to placebo, with similar efficacy and safety to Paliperidone Palmitate 1-month (PP1M) (Carpiniello et al. Drug Des. Devel. Ther. 2016; 10 1731–1742). OBJECTIVES: The main objecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero Guillena, S. L., Plasencia Garcia de Diego, B. O., Gomez Gonzalez, J., Gotor Sánchez-Luengo, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434325/
http://dx.doi.org/10.1192/j.eurpsy.2023.1041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434325/
http://dx.doi.org/10.1192/j.eurpsy.2023.1041

Ejemplares similares